Venus Remedies Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, hit its maximum allowed daily gain of 4.99% within a 5% price band, closing at Rs 1778.5. This price band capped the upside, effectively freezing trading at the ceiling price. The total traded volume stood at 61,991 shares, with a turnover of ₹10.58 crore. The wide intraday range of Rs 163.5, from a low of Rs 1615 to the high circuit price, indicates significant volatility and strong buying interest throughout the session. The circuit lock signals unfilled demand, as buyers were willing to pay more but were unable to transact beyond the upper limit — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Despite the upper circuit, delivery volumes tell a more cautious story. On 21 Jul, delivery volume was 2,230 shares, marking a sharp decline of 64.59% compared to the 5-day average delivery volume. This fall suggests that while the stock attracted buyers at the circuit price, fewer investors were taking shares for long-term holding. The total traded volume was mechanically suppressed due to the circuit lock, but the drop in delivery volume points to a speculative element in the session’s buying activity rather than strong conviction. This divergence between price action and delivery volume raises questions about the sustainability of the move — is Venus Remedies Ltd's upper circuit surge backed by improving fundamentals or is this a liquidity-driven micro-cap move?

Moving Averages and Trend Context

Venus Remedies Ltd closed above its 50-day, 100-day, and 200-day moving averages, signalling a medium- to long-term bullish trend. However, it remained below its 5-day and 20-day moving averages, indicating some short-term resistance or consolidation. This mixed moving average picture suggests the stock is in a transitional phase, with the upper circuit potentially marking a breakout attempt. The weighted average price was closer to the day’s low, reflecting that more volume traded near Rs 1615 rather than the circuit price, which tempers the strength of the rally somewhat.

Liquidity and Market Capitalisation

With a market capitalisation of approximately ₹2,323 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is modest, with a trade size capacity of just ₹0.18 crore based on 2% of the 5-day average traded value. This limited liquidity means that while the upper circuit is a notable event, the stock’s thin order book and small trade size capacity pose significant risks for investors attempting to enter or exit sizeable positions. The circuit lock amplifies this risk by restricting price movement and reducing tradable volume — but with near-zero liquidity and a Rs 2,323 crore market cap, should you be chasing Venus Remedies Ltd?

Intraday Price Action

The stock exhibited high volatility during the session, with an intraday volatility of 6.26%. It opened with a gap down of 4.3%, touched a low of Rs 1615, and then rallied sharply to hit the upper circuit at Rs 1778.5. This wide range of Rs 163.5 highlights a recovery from early weakness, culminating in a strong finish at the circuit price. The narrow trading band near the close reflects the price lock mechanism, which prevented further upside despite persistent buying interest.

Fundamental Context

Operating within the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd has seen a recent trend reversal after four consecutive days of decline. The stock outperformed its sector by 5.29% on the day, while the Sensex and sector indices posted marginal losses. This relative strength is noteworthy, though the fundamental drivers behind the price action require deeper analysis beyond the scope of this session’s trading data.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit by Venus Remedies Ltd reflects strong buying interest capped by exchange-imposed price limits. However, the sharp decline in delivery volume tempers the conviction narrative, suggesting that much of the session’s buying may be speculative or intraday-driven rather than long-term accumulation. The stock’s position above key moving averages supports a bullish trend, but the short-term moving averages indicate some resistance. Crucially, the micro-cap status and limited liquidity heighten the risk profile, as the thin order book can exaggerate price moves and complicate trade execution. The circuit locked in gains but also locked out buyers who arrived late — after a 4.99% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today